nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—breast cancer	0.597	0.93	CbGaD
Tofisopam—CYP3A4—breast cancer	0.0449	0.0699	CbGaD
Tofisopam—CYP3A4—Exemestane—breast cancer	0.0306	0.133	CbGbCtD
Tofisopam—CYP3A4—Letrozole—breast cancer	0.026	0.113	CbGbCtD
Tofisopam—CYP3A4—Anastrozole—breast cancer	0.0232	0.101	CbGbCtD
Tofisopam—CYP3A4—Toremifene—breast cancer	0.0212	0.0921	CbGbCtD
Tofisopam—CYP3A4—Fulvestrant—breast cancer	0.0197	0.0856	CbGbCtD
Tofisopam—CYP3A4—Thiotepa—breast cancer	0.0175	0.0763	CbGbCtD
Tofisopam—CYP3A4—Ixabepilone—breast cancer	0.016	0.0698	CbGbCtD
Tofisopam—CYP3A4—Lapatinib—breast cancer	0.0154	0.0672	CbGbCtD
Tofisopam—CYP3A4—Raloxifene—breast cancer	0.0117	0.0509	CbGbCtD
Tofisopam—CYP3A4—Vinorelbine—breast cancer	0.00857	0.0373	CbGbCtD
Tofisopam—CYP3A4—Tamoxifen—breast cancer	0.00774	0.0336	CbGbCtD
Tofisopam—CYP3A4—Mitoxantrone—breast cancer	0.00754	0.0328	CbGbCtD
Tofisopam—CYP3A4—Paclitaxel—breast cancer	0.00602	0.0262	CbGbCtD
Tofisopam—CYP3A4—Irinotecan—breast cancer	0.00594	0.0258	CbGbCtD
Tofisopam—CYP3A4—Vinblastine—breast cancer	0.00528	0.023	CbGbCtD
Tofisopam—CYP3A4—Docetaxel—breast cancer	0.00435	0.0189	CbGbCtD
Tofisopam—PDE2A—mammary gland—breast cancer	0.00394	0.109	CbGeAlD
Tofisopam—PDE2A—nipple—breast cancer	0.00326	0.0901	CbGeAlD
Tofisopam—CYP3A4—Doxorubicin—breast cancer	0.00325	0.0141	CbGbCtD
Tofisopam—PDE4A—mammary gland—breast cancer	0.00271	0.0749	CbGeAlD
Tofisopam—PDE2A—uterus—breast cancer	0.00181	0.0501	CbGeAlD
Tofisopam—PDE2A—pituitary gland—breast cancer	0.00178	0.0492	CbGeAlD
Tofisopam—PDE2A—adipose tissue—breast cancer	0.00177	0.049	CbGeAlD
Tofisopam—PDE10A—adipose tissue—breast cancer	0.00177	0.049	CbGeAlD
Tofisopam—PDE2A—female reproductive system—breast cancer	0.00163	0.045	CbGeAlD
Tofisopam—PDE2A—adrenal gland—breast cancer	0.00159	0.044	CbGeAlD
Tofisopam—PDE10A—adrenal gland—breast cancer	0.00159	0.044	CbGeAlD
Tofisopam—PDE10A—female gonad—breast cancer	0.00148	0.041	CbGeAlD
Tofisopam—PDE2A—endocrine gland—breast cancer	0.00138	0.0381	CbGeAlD
Tofisopam—PDE4A—adipose tissue—breast cancer	0.00122	0.0337	CbGeAlD
Tofisopam—Colchicine—ABCC1—breast cancer	0.00114	0.326	CrCbGaD
Tofisopam—PDE4A—adrenal gland—breast cancer	0.00109	0.0303	CbGeAlD
Tofisopam—PDE4A—female gonad—breast cancer	0.00102	0.0282	CbGeAlD
Tofisopam—PDE3A—adipose tissue—breast cancer	0.00101	0.0279	CbGeAlD
Tofisopam—PDE2A—lymph node—breast cancer	0.000954	0.0264	CbGeAlD
Tofisopam—PDE10A—lymph node—breast cancer	0.000954	0.0264	CbGeAlD
Tofisopam—PDE3A—female reproductive system—breast cancer	0.000928	0.0256	CbGeAlD
Tofisopam—PDE3A—adrenal gland—breast cancer	0.000906	0.025	CbGeAlD
Tofisopam—PDE3A—female gonad—breast cancer	0.000844	0.0233	CbGeAlD
Tofisopam—PDE3A—endocrine gland—breast cancer	0.000785	0.0217	CbGeAlD
Tofisopam—PDE4A—lymph node—breast cancer	0.000656	0.0181	CbGeAlD
Tofisopam—Verapamil—SLCO1B1—breast cancer	0.000619	0.177	CrCbGaD
Tofisopam—PDE3A—lymph node—breast cancer	0.000543	0.015	CbGeAlD
Tofisopam—Verapamil—ABCC1—breast cancer	0.000511	0.146	CrCbGaD
Tofisopam—Colchicine—CYP3A4—breast cancer	0.000301	0.086	CrCbGaD
Tofisopam—CYP3A4—female reproductive system—breast cancer	0.000297	0.00822	CbGeAlD
Tofisopam—Verapamil—ABCG2—breast cancer	0.000269	0.0771	CrCbGaD
Tofisopam—CYP3A4—endocrine gland—breast cancer	0.000252	0.00695	CbGeAlD
Tofisopam—Colchicine—ABCB1—breast cancer	0.00025	0.0716	CrCbGaD
Tofisopam—Verapamil—CYP2D6—breast cancer	0.000157	0.0449	CrCbGaD
Tofisopam—Verapamil—CYP3A4—breast cancer	0.000135	0.0385	CrCbGaD
Tofisopam—Verapamil—ABCB1—breast cancer	0.000112	0.0321	CrCbGaD
Tofisopam—PDE4A—Signaling Pathways—FGFR2—breast cancer	1.11e-05	0.000126	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAPK3—breast cancer	1.11e-05	0.000126	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SPP1—breast cancer	1.1e-05	0.000125	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CXCL8—breast cancer	1.1e-05	0.000124	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CXCL8—breast cancer	1.09e-05	0.000124	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HRAS—breast cancer	1.09e-05	0.000123	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB3—breast cancer	1.09e-05	0.000123	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGFR2—breast cancer	1.08e-05	0.000123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MYC—breast cancer	1.08e-05	0.000123	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TGFB1—breast cancer	1.08e-05	0.000122	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2—breast cancer	1.07e-05	0.000122	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TERT—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1B—breast cancer	1.07e-05	0.000121	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AKT1—breast cancer	1.06e-05	0.00012	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EGFR—breast cancer	1.06e-05	0.00012	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CASP3—breast cancer	1.05e-05	0.000119	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2—breast cancer	1.05e-05	0.000119	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2—breast cancer	1.04e-05	0.000118	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL6—breast cancer	1.04e-05	0.000118	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TERT—breast cancer	1.04e-05	0.000118	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGFR1—breast cancer	1.04e-05	0.000118	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HIF1A—breast cancer	1.02e-05	0.000116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCND1—breast cancer	1.02e-05	0.000116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JUN—breast cancer	1.02e-05	0.000116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CTNNB1—breast cancer	1.01e-05	0.000115	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGFR1—breast cancer	1.01e-05	0.000115	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SYNJ2—breast cancer	1e-05	0.000114	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—LEP—breast cancer	9.98e-06	0.000113	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KRAS—breast cancer	9.98e-06	0.000113	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HIF1A—breast cancer	9.95e-06	0.000113	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MMP9—breast cancer	9.91e-06	0.000112	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CAV1—breast cancer	9.89e-06	0.000112	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1A—breast cancer	9.87e-06	0.000112	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—AKT1—breast cancer	9.87e-06	0.000112	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTEN—breast cancer	9.85e-06	0.000112	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KDR—breast cancer	9.78e-06	0.000111	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—LEP—breast cancer	9.71e-06	0.00011	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK8—breast cancer	9.63e-06	0.000109	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CAV1—breast cancer	9.62e-06	0.000109	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AKT1—breast cancer	9.61e-06	0.000109	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ESR1—breast cancer	9.53e-06	0.000108	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KDR—breast cancer	9.52e-06	0.000108	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FN1—breast cancer	9.42e-06	0.000107	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NDUFS3—breast cancer	9.32e-06	0.000106	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NFKBIA—breast cancer	9.3e-06	0.000106	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ESR1—breast cancer	9.27e-06	0.000105	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOTCH1—breast cancer	9.21e-06	0.000105	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CA—breast cancer	9.17e-06	0.000104	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FN1—breast cancer	9.16e-06	0.000104	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SRC—breast cancer	9.13e-06	0.000104	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NFKBIA—breast cancer	9.05e-06	0.000103	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KIT—breast cancer	9.01e-06	0.000102	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CG—breast cancer	9.01e-06	0.000102	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APC—breast cancer	9.01e-06	0.000102	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOTCH1—breast cancer	8.96e-06	0.000102	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGF—breast cancer	8.91e-06	0.000101	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—breast cancer	8.9e-06	0.000101	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—breast cancer	8.87e-06	0.000101	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—STAT3—breast cancer	8.81e-06	9.99e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KIT—breast cancer	8.77e-06	9.95e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CG—breast cancer	8.77e-06	9.95e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APC—breast cancer	8.77e-06	9.95e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CHST9—breast cancer	8.76e-06	9.94e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGF—breast cancer	8.66e-06	9.83e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAPK3—breast cancer	8.63e-06	9.79e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HRAS—breast cancer	8.48e-06	9.62e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—BRAF—breast cancer	8.47e-06	9.61e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK3—breast cancer	8.41e-06	9.55e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAPK3—breast cancer	8.4e-06	9.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—COX11—breast cancer	8.31e-06	9.42e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1—breast cancer	8.25e-06	9.36e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT2—breast cancer	8.24e-06	9.35e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—BRAF—breast cancer	8.24e-06	9.35e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—EGFR—breast cancer	8.21e-06	9.32e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MYC—breast cancer	8.18e-06	9.29e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TGFB1—breast cancer	8.16e-06	9.26e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL6—breast cancer	8.12e-06	9.21e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1—breast cancer	8.03e-06	9.11e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT2—breast cancer	8.02e-06	9.1e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EGFR—breast cancer	8e-06	9.08e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—EGFR—breast cancer	7.99e-06	9.06e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CD—breast cancer	7.92e-06	8.99e-05	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CA—breast cancer	7.85e-06	8.9e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SERPINE1—breast cancer	7.84e-06	8.89e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—KRAS—breast cancer	7.76e-06	8.8e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CD—breast cancer	7.71e-06	8.74e-05	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CA—breast cancer	7.63e-06	8.66e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SERPINE1—breast cancer	7.62e-06	8.65e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CDA—breast cancer	7.6e-06	8.62e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SHMT1—breast cancer	7.6e-06	8.62e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KRAS—breast cancer	7.56e-06	8.58e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—KRAS—breast cancer	7.54e-06	8.56e-05	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AKT1—breast cancer	7.49e-06	8.5e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOS3—breast cancer	7.48e-06	8.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.31e-06	8.3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A5—breast cancer	7.31e-06	8.3e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOS3—breast cancer	7.28e-06	8.26e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CA—breast cancer	7.13e-06	8.08e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MDM2—breast cancer	7.1e-06	8.05e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RAF1—breast cancer	7.07e-06	8.02e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APRT—breast cancer	7.06e-06	8.01e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RELA—breast cancer	7.04e-06	7.99e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB2—breast cancer	7e-06	7.94e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CA—breast cancer	6.95e-06	7.88e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CA—breast cancer	6.93e-06	7.86e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MTOR—breast cancer	6.9e-06	7.83e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CB—breast cancer	6.9e-06	7.83e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MDM2—breast cancer	6.9e-06	7.83e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RAF1—breast cancer	6.88e-06	7.81e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RELA—breast cancer	6.85e-06	7.77e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB2—breast cancer	6.81e-06	7.72e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—breast cancer	6.72e-06	7.63e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MTOR—breast cancer	6.72e-06	7.62e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CB—breast cancer	6.72e-06	7.62e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.64e-06	7.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ESRRA—breast cancer	6.64e-06	7.53e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CXCL8—breast cancer	6.64e-06	7.53e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HRAS—breast cancer	6.59e-06	7.48e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1B—breast cancer	6.48e-06	7.35e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CXCL8—breast cancer	6.45e-06	7.32e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HRAS—breast cancer	6.43e-06	7.29e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HRAS—breast cancer	6.41e-06	7.28e-05	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AKT1—breast cancer	6.41e-06	7.27e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CASP3—breast cancer	6.35e-06	7.21e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2—breast cancer	6.34e-06	7.19e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL6—breast cancer	6.31e-06	7.16e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1B—breast cancer	6.3e-06	7.15e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPI—breast cancer	6.29e-06	7.14e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HADHB—breast cancer	6.29e-06	7.14e-05	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AKT1—breast cancer	6.24e-06	7.07e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCND1—breast cancer	6.18e-06	7.01e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CASP3—breast cancer	6.18e-06	7.01e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JUN—breast cancer	6.17e-06	7e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2—breast cancer	6.17e-06	7e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL6—breast cancer	6.15e-06	6.98e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL6—breast cancer	6.14e-06	6.96e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CTNNB1—breast cancer	6.12e-06	6.95e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCND1—breast cancer	6.01e-06	6.82e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDH7A1—breast cancer	6e-06	6.81e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDH1A1—breast cancer	6e-06	6.81e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MMP9—breast cancer	6e-06	6.81e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JUN—breast cancer	6e-06	6.81e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1A—breast cancer	5.98e-06	6.79e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTEN—breast cancer	5.97e-06	6.77e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CTNNB1—breast cancer	5.96e-06	6.76e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MMP9—breast cancer	5.84e-06	6.62e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK8—breast cancer	5.84e-06	6.62e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AKT1—breast cancer	5.82e-06	6.6e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1A—breast cancer	5.82e-06	6.6e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTEN—breast cancer	5.8e-06	6.59e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—UMPS—breast cancer	5.76e-06	6.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FHL2—breast cancer	5.76e-06	6.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NME1—breast cancer	5.76e-06	6.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PHGDH—breast cancer	5.76e-06	6.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ADSL—breast cancer	5.76e-06	6.53e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK8—breast cancer	5.68e-06	6.44e-05	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AKT1—breast cancer	5.68e-06	6.44e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AKT1—breast cancer	5.66e-06	6.42e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—BRIP1—breast cancer	5.65e-06	6.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LDHB—breast cancer	5.65e-06	6.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HPSE—breast cancer	5.65e-06	6.41e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SRC—breast cancer	5.53e-06	6.28e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—breast cancer	5.39e-06	6.11e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SRC—breast cancer	5.38e-06	6.11e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HMMR—breast cancer	5.35e-06	6.07e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTA3—breast cancer	5.35e-06	6.07e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCC1—breast cancer	5.35e-06	6.07e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—STAT3—breast cancer	5.34e-06	6.05e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—breast cancer	5.24e-06	5.95e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—STAT3—breast cancer	5.19e-06	5.89e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.18e-06	5.88e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK3—breast cancer	5.1e-06	5.78e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK3—breast cancer	4.96e-06	5.63e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MYC—breast cancer	4.96e-06	5.63e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TGFB1—breast cancer	4.95e-06	5.61e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA9—breast cancer	4.89e-06	5.55e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTA4—breast cancer	4.89e-06	5.55e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EGFR—breast cancer	4.85e-06	5.5e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MYC—breast cancer	4.82e-06	5.47e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TGFB1—breast cancer	4.81e-06	5.46e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTA2—breast cancer	4.77e-06	5.41e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX2—breast cancer	4.77e-06	5.41e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EGFR—breast cancer	4.72e-06	5.35e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SULT1A1—breast cancer	4.71e-06	5.35e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX4—breast cancer	4.71e-06	5.35e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—IDH1—breast cancer	4.6e-06	5.22e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTA1—breast cancer	4.6e-06	5.22e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KRAS—breast cancer	4.58e-06	5.2e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NAT2—breast cancer	4.55e-06	5.16e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KRAS—breast cancer	4.46e-06	5.06e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CA—breast cancer	4.21e-06	4.78e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CA—breast cancer	4.09e-06	4.65e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—breast cancer	4.07e-06	4.62e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MED12—breast cancer	3.99e-06	4.53e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—DPYD—breast cancer	3.99e-06	4.53e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—breast cancer	3.96e-06	4.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDOA—breast cancer	3.93e-06	4.46e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HRAS—breast cancer	3.89e-06	4.42e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NCOA3—breast cancer	3.81e-06	4.33e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HRAS—breast cancer	3.79e-06	4.3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A2—breast cancer	3.79e-06	4.3e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL6—breast cancer	3.73e-06	4.23e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CPT1A—breast cancer	3.71e-06	4.21e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCG2—breast cancer	3.71e-06	4.21e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MTR—breast cancer	3.71e-06	4.21e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HPGDS—breast cancer	3.64e-06	4.13e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL6—breast cancer	3.63e-06	4.11e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HBA1—breast cancer	3.62e-06	4.1e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ACHE—breast cancer	3.53e-06	4e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT1—breast cancer	3.53e-06	4e-05	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT1—breast cancer	3.44e-06	3.9e-05	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT1—breast cancer	3.34e-06	3.8e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP17A1—breast cancer	3.34e-06	3.79e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ENO1—breast cancer	3.31e-06	3.75e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS1—breast cancer	3.31e-06	3.75e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP2D6—breast cancer	3.24e-06	3.68e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NCOA2—breast cancer	3.18e-06	3.61e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FASN—breast cancer	3.09e-06	3.5e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—BCHE—breast cancer	3.07e-06	3.49e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A5—breast cancer	3.04e-06	3.45e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NQO1—breast cancer	2.93e-06	3.33e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A1—breast cancer	2.93e-06	3.33e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1B1—breast cancer	2.81e-06	3.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.76e-06	3.13e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NCOA1—breast cancer	2.68e-06	3.04e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP19A1—breast cancer	2.64e-06	3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—STK11—breast cancer	2.64e-06	3e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—COMT—breast cancer	2.46e-06	2.79e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTP1—breast cancer	2.45e-06	2.78e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HMOX1—breast cancer	2.41e-06	2.74e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ITPR1—breast cancer	2.41e-06	2.73e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCB1—breast cancer	2.32e-06	2.63e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TYMS—breast cancer	2.27e-06	2.58e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NCOR1—breast cancer	2.25e-06	2.55e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTM1—breast cancer	2.25e-06	2.55e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.25e-06	2.55e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPX1—breast cancer	2.15e-06	2.44e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1A1—breast cancer	2.13e-06	2.42e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ERCC2—breast cancer	2.11e-06	2.4e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MTHFR—breast cancer	1.99e-06	2.25e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CAV1—breast cancer	1.83e-06	2.08e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CG—breast cancer	1.67e-06	1.89e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CD—breast cancer	1.47e-06	1.66e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALB—breast cancer	1.45e-06	1.64e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NOS3—breast cancer	1.39e-06	1.57e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CB—breast cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—breast cancer	1.27e-06	1.44e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTEN—breast cancer	1.11e-06	1.25e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CA—breast cancer	7.8e-07	8.84e-06	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AKT1—breast cancer	6.37e-07	7.23e-06	CbGpPWpGaD
